Medtech
CES 2023: Familiar Tech Company Launches New OTC Hearing Aid
The Consumer Trade Association (CTA) named the HP Hearing PRO self-fitting over-the-counter (OTC) hearing aids as one of their CES 2023 Innovation Awards…
The Consumer Trade Association (CTA) named the HP Hearing PRO self-fitting over-the-counter (OTC) hearing aids as one of their CES 2023 Innovation Awards Honorees. Perhaps even more significantly, the FDA granted clearance to market the Nuheara-designed hearing aids in October 2022 following a successful clinical trial earlier the same year. The hearing ads may be sold OTC as medical devices.
The newly-branded HP Hearing PRO by Nuheara are available for pre-order now for $699, with shipments expected to start at the end of March, 2023. The self-fitting feature means that the purchaser does not need a professional audiologist to help set up the devices. Instead, the HP Hearing App steps them through the adjustment process. The app also allows the user to control the hearing aids wireless to adjust for different settings and conditions.
In addition, the earbuds include active noise cancellation (ANC) to reduce background sounds, built-in rechargeable batteries and Bluetooth support to connect to streaming devices. They are expected to last up to eight hours on a charge (five hours when streaming using the Bluetooth connection), and the storage case can recharge the hearing aids.
In addition to direct online sales, the company plans to make the hearing aids available through retailers including Best Buy and Crutchfield.
ETF Talk: AI is ‘Big Generator’
Second nature comes alive Even if you close your eyes We exist through this strange device — Yes, “Big Generator” Artificial intelligence (AI) has…
Apple gets an appeals court win for its Apple Watch
Apple has at least a couple more weeks before it has to worry about another sales ban.
Federal court blocks ban on Apple Watches after Apple appeal
A federal appeals court has temporarily blocked a sweeping import ban on Apple’s latest smartwatches while the patent dispute winds its way through…
